Antiretroviral Drugs Current Events | Antiretroviral Drugs News
|
| Page
1 of
30 |
588 Results |
|
|
|
Sort By:
Page Views | Date |
Action needed to avoid HIV drug resistance in Africa
We should stop and think about the risks of resistance, and ways of minimising them, before increasing access to antiretroviral therapy in Africa, argue researchers in this week's BMJ. view more (2004-01-29)
ADVERSE EFFECTS OF ANTIRETROVIRAL TREATMENT FOR HIV INFECTION (p1320)
It is well known that treatment of HIV-1 infection (that may lead to AIDS) has side effects, but there are few studies of how many people having treatment are affected by adverse reactions. In a study of 1160 people receiving antiretroviral treatment, published in The Lancet this week, Jacques Fallon and colleagues from the Swiss HIV Cohort Study... view more... (2001-10-17)
LIPODYSTROPHY RISK FROM HIV-1 THERAPY (p 592)
The risk of lipodystrophy (abnormal fat distribution) in HIV-1 individuals undergoing antiretroviral therapy cannot be attributed to one antiretroviral agent, conclude authors of a study in this week's issue of THE LANCET. Lipodystrophy among HIV-1-infected patients receiving antiretroviral therapy was formally described as a clinical entity in... view more... (2001-02-21)
EARLY ASSESSMENT PREDICTS LONG-TERM EFFICACY OF HIV-1 ANTIRETROVIRAL THERAPY (p 1760)
A study in this week's issue of THE LANCET highlights how very early (one week) assessment can reliably predict the long-term effectiveness of antiretroviral therapy for HIV-1. Early assessment of antiretroviral drug efficacy is important for the prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective and toxic... view more... (2001-11-21)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Human testis harbors HIV-1 in resident immune cells
Researchers have demonstrated HIV replication within resident immune cells of the testis, providing an explanation for the persistence of virus in semen even after effective highly active antiretroviral therapy. view more (2006-11-27)
Ethnic differences in response to HIV medicines
Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma lipids in patients with HIV-1 on HAART (highly active antiretroviral therapy). view more (2006-01-24)
HIV integrase inhibitor effective for patients beginning antiretroviral treatment
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs. view more (2009-08-03)
Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown. view more (2008-10-22)
HIV drug resistance is increasing in the UK
The prevalence of transmitted HIV drug resistance in the United Kingdom is increasing, according to a study in this week's BMJ. This finding emphasises the urgent need for new approaches to encourage safer sexual behaviour. A total of 69 patients infected with HIV between June 1994 and August 2000 were evaluated for resistance within 18 months of... view more... (2001-05-02)
Successful Implementation Of Pilot Study For Hiv Antiretroviral Therapy In Uganda (p 34)
Authors of a study in this week's issue of THE LANCET report on the successful implementation of a UNAIDS/Uganda Health Ministry initiative to provide antiretroviral treatment to people with HIV/AIDS in Uganda. Little is known about how to implement complex HIV-1 treatment programmes in resource-limited countries. Paul Weidle from the Centers for... view more... (2002-07-03)
Long-term HIV treatment may reduce risk for atherosclerosis
Antiretroviral drugs for HIV do not increase the risk for coronary atherosclerosis, a central risk factor for heart disease, according to a study led by the University of Pittsburgh Graduate School of Public Health to be published in the Aug. 8 issue of the journal AIDS and available online today. view more (2008-08-05)
OHSU researchers discover possible HIV therapy in an animal study
Researchers have published a new study this week suggesting an important component of the immune system damaged by AIDS can possibly be replaced. view more (2006-06-09)
Aids : Effectiveness of antiretroviral therapy demonstrated in Africa
Tritherapies using antiretroviral drugs have proved their worth in industrialized countries in the fight against Aids. However, in Sub-Saharan Africa, where 70 % of people infected with HIV live, access to such treatments is extremely limited. High cost, complicated procedures, combined with inadequate infrastructures for following up patients or... view more... (2002-06-27)
HIV persists in the gut despite long-term HIV therapy
Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. view more (2008-02-14)
Certain HIV treatment less effective when used with anti-TB therapy
Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy. view more (2008-08-04)
HIV Mortality in India Drops with Introduction of Generic Antiretroviral Therapy
The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online. view more (2005-10-20)
To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says
The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population. view more (2006-11-10)
Breastfeeding now safer for infants of HIV-infected mothers
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding. view more (2008-02-05)
|
|
| Page
1 of
30 |
588 Results |
|
|
|
Sort By:
Page Views | Date |
|
